Lowenstein Sandler represents PeriGen Inc. (PeriGen), a leading provider of perinatal health care software solutions, in its sale to Halma plc.
PeriGen’s software incorporates advanced statistical analysis features to enhance clinical efficiency and standardization of care during childbirth. The PeriWatch® platform provides consistent analysis and timely display of complex data in real time to promote better human recognition and communication about impending problems during labor, enabling clinicians to spend more time on direct patient care and less time on manual calculations and data manipulation. Today, PeriGen serves over 300 hospitals in the United States, and its solutions are deployed across 500,000 childbirths annually.
Halma is a global group of lifesaving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day; it is listed on the London Stock Exchange (LON: HLMA) and employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the United States, and Asia Pacific.
The Lowenstein deal team includes Sam E. Khan, Christopher C. Henry, Rachel Ingwer, Lauren M. Troeller, Diana Kim, Kimberly E. Lomot, Megan Monson, Taryn E. Cannataro, Eric Jesse, Bryan Sterba, Matthew P. Hintz, David Toma, James C. Shehan, Edgar R. Hidalgo CIPP/US, Mark S. Heinzelmann, Emily B. Sklar, Megan Williams, Latoya Bethune, and Amanda Sewanan.
About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.
